Abstract: A display panel includes a substrate and display pixels. The display pixels are disposed on the substrate, and each of the display pixels includes pad sets, light-emitting devices, a first connecting wire, a second connecting wire, and first cutting regions. Each pad set has a first pad and a second pad. The light-emitting devices are electrically bonded to at least part of the pad sets. The first connecting wire is electrically connected to the first pads of a plurality of first pad sets of the pad sets. The second connecting wire is electrically connected to the second pads of the pad sets. The first cutting regions are disposed on one side of each of the first pad sets. Two first connecting portions of the first connecting wire and the second connecting wire connecting each of the first pad sets are located in one of the first cutting regions.

Abstract: A transmission interface between at least a first module and a second module is proposed. The transmission interface includes at least two physical transmission mediums. Each physical transmission medium is arranged to carry a multiplexed signal in which at least two signals are integrated. The at least two physical transmission mediums include a first physical transmission medium arranged to carry a first multiplexed signal including a first IF signal and a reference clock signal. The first IF signal and the reference clock signal are at different frequencies.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: A process for producing a polyester polyol includes the steps of: (a) preparing a diol composition which includes a C2-C9 short-chain diol component and a diol monomeric component of Formula (I) defined herein in a weight ratio of the C2-C9 short-chain diol component to the diol monomeric component of Formula (I) of larger than 0 and less than 1.6, (b) preparing a dicarbonyl composition which includes one selected from the group consisting of a dicarboxylic acid component, a dicarboxylic anhydride component, and a combination thereof, and (c) subjecting the diol composition and the dicarbonyl composition to a polycondensation reaction.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating, preventing or treating postmenopausal or climacteric symptoms, which include but are not limited to bone loss, bone remodeling, hot flushes and vaginal atrophy. The present invention also provides methods for modulating, preventing or treating postmenopausal or climacteric symptoms using the compositions disclosed herein.

Abstract: A manufacturing method and a manufacturing equipment of a thin film transistor substrate are provided. In the manufacturing method, after forming a gate and a gate insulating layer of a thin film transistor, a semiconductor layer and a first protection layer are sequentially deposited. After patterning the first protection layer, the patterned first protection layer is used as a mask to pattern the semiconductor layer to form a semiconductor channel of the thin film transistor. By the above solution, the invention can reduce the number of mask and therefore is beneficial to reduce the cost.

Abstract: The present discloses a manufacturing method for an array substrate, an array substrate and a display panel. The manufacturing method includes sequentially forming a first metal layer, an insulation layer, a first thin-film layer, a second metal layer and an inorganic layer on a substrate; forming a color resist layer on the inorganic layer; forming an organic layer on the inorganic layer and the color resist layer; digging a hole on the organic and the inorganic layer to form a first through hole so as to uncover a portion of the second metal layer; forming a second thin-film layer on the organic layer and the uncovered second metal layer.

Abstract: The method for direct detection of lipid binding agents in membrane includes dissolving a lipid in an organic solvent in a container; evaporating off the organic solvent to create a lipid film on the inside wall of the container; adding a buffer solution; adding a known volume of a membrane active agent to the buffer solution; incubating the solution in the dark for a period of time; removing the buffer solution from the container to provide a solution of sample A; washing the container with a buffer solution; adding an organic solvent while stirring the container to dissolve the lipid film to create a homogenous solution B; and measuring the absorbance of the samples A and B by absorption spectroscopy. The method may further include developing a universal probability function to test and quantify a membrane-based cytotoxicity of general drug candidates.

Abstract: A manufacturing method and a manufacturing equipment of a thin film transistor substrate are provided. In the manufacturing method, after forming a gate and a gate insulating layer of a thin film transistor, a semiconductor layer and a first protection layer are sequentially deposited. After patterning the first protection layer, the patterned first protection layer is used as a mask to pattern the semiconductor layer to form a semiconductor channel of the thin film transistor. By the above solution, the invention can reduce the number of mask and therefore is beneficial to reduce the cost.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating bone remodeling, and prevention and treatment of osteoporosis.

Abstract: The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating bone remodeling, and prevention and treatment of osteoporosis.

Abstract: The present invention provides a method of forming a transparent conductive layer on a substrate, including: applying a conductive composition containing a conductive polymer onto the substrate to form the transparent conductive layer thereon, forming a patterned protection layer on the transparent conductive layer to define a transparent conductive layer region covered by the protection layer and a transparent conductive layer region not covered by the protection layer; performing a wet etching process on the transparent conductive layer region not covered by the protection layer; and removing the protection layer, wherein an annealing process is performed on the transparent conductive layer before or after the wet etching process. The method of the present invention can reduce the chromatic aberration between the etched transparent conductive layer and the un-etched transparent conductive layer.

Abstract: A phytoestrogen blend was developed using a pharmaceutical platform technology to identify the time course of active components and effect time course of these components in the biophase after administration of a red clover extract. This phytoestrogen blend consists of biochanin A, daidzein, equol and genistein. The recommended daily dosage ranges from 5 to 200 mg of total isoflavone.

Abstract: The present invention provides a method for preparing a conductive polymer dispersion, including: adding a conductive compound, a polyanion, and an oxidant to a solvent; and polymerizing the conductive compound with microwaves. The present invention further provides a conductive polymer material made from the conductive polymer dispersion and a solid electrolyte capacitor using the conductive polymer material. Compared to a conventional method, the conductive polymer is prepared by the method of the present invention in a shorter time and environmental friendly. Moreover, the conductive polymer material made from the dispersion exhibits a high conductivity.

Abstract: Disclosed in this specification is a method for identifying at least one aptamer that can bind to a bio-molecular target. The aptamer is designed in silico based on the structure of the target molecule. The process includes the steps of determining a first seed residue and growing an oligomer, one residue at a time, while maximizing the entropy of target-oligomer complex or minimizing the binding energy after the addition of each oligomer.

Abstract: Disclosed in this specification is a method for identifying at least one aptamer that can bind to a bio-molecular target. The aptamer is designed in silico based on the structure of the target molecule. The process includes the steps of determining a first seed residue and growing an oligomer, one residue at a time, while maximizing the entropy of target-oligomer complex or minimizing the binding energy after the addition of each oligomer.